cognitive cybersecurity intelligence

News and Analysis

Search

Evonetix closes $24M financing

Evonetix Ltd, a synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a $24 million financing round, extending its total series B funding to over $54 million.

This fundraise was led by existing investor Foresite Capital, with Molten Ventures,…

Source: www.labiotech.euRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts